Effect of three different doses of urapidil on blood glucose concentrations in the streptozotocin diabetic rat

European Journal of Anaesthesiology

Volumn 19, Issue 7, 2002, Pages 504-509

  Ittner, K P ^a   Bucher, M ^a   Zimmermann, M ^a   Grobecker, H F ^a   Kramer B K ^a   Taeger, K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adrenergic agents; Adrenergic alpha antagonists; Antihypertensive agents; Diabetes mellitus; Experimental; Nitrosourea compounds; Serotonin agonists; Streptozocin; Urapidil

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DEPOT INSULIN S; GLUCOSE; INSULIN; SEROTONIN 1A AGONIST; URAPIDIL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; INSULIN TREATMENT; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DRINKING; EXPERIMENTAL DIABETES MELLITUS; FOOD; TIME; WISTAR RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; FOOD; MALE; PIPERAZINES; RATS; RATS, WISTAR; STREPTOZOCIN; TIME FACTORS;

EID: 0035997244     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-200207000-00007     Document Type: Article

References (30)

1. Perioperative care of diabetic patients
2. Evaluation of the patient with endocrine disease or diabetes mellitus
3. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies
4. Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery
5. Haemodynamic effects of intravenous urapidil in patients with advanced left ventricular failure
6. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents
7. Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure
8. Drugs interacting with alpha adrenoceptors
9. The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension
10. Importance of central nervous system serotonin-1 A receptors for mediating the hypotensive effect of urapidil
11. 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat
12. Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats
13. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM)
14. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension
15. Principles of toxicology and treatment of poisoning
16. Kerosis in rats with streptozotocin-induced diabetes
17. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system
18. A comparison of statistical techniques to evaluate the performance of the Glucometer Elite blood glucose meter
19. P values
20. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function
21. 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity
22. Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats
23. The effect of urapidil and ramipril on hyperglycemia in streptozotocin diabetic rats
24. Metabolic effects of anti -hypertensive treatment with nifedipine or furosemide: A double-blind, cross-over study
25. The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects
26. Indications of pre- and post-synaptic 5-HT1A receptor interactions in feeding behavior and neuroendocrine regulation
27. Serotonin
28. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats
29. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1 A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord
30. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1 A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm